Recent FDA Committee Vote Could Speed Multiple Mye
An FDA committee voted unanimously last month to approve a new clinical endpoint, minimal residual disease, when evaluating proposed drugs to treat multipl
Source: newswise.com
Stay updated with breaking news from Seanm Devlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An FDA committee voted unanimously last month to approve a new clinical endpoint, minimal residual disease, when evaluating proposed drugs to treat multipl
Investegate announcements from MDS Foundation, Inc. (963786), Molecular International Prognostic Scoring System Developed for Myelodysplastic Syndromes
Efficient, Accurate Risk Stratification Will Transform Patient CareYARDVILLE, N.J., June 12, 2022 (GLOBE NEWSWIRE) -- Today, the MDS Foundation announced the development of a new prognostic scoring system
Efficient, Accurate Risk Stratification Will Transform Patient Care...